Skip to main content

Table 3 Classification of genes enriched in the cell cycle from Reactome pathways among the 434 SRTNS

From: SNRPD1 confers diagnostic and therapeutic values on breast cancers through cell cycle regulation

M

M checkpoint

S

S checkpoint

Rest

Common

AAAS

NCAPG2

BUB1B

NDC80

CDCA5

CCNA2

BLM

PSMD3

CDCA5

NCAPH

CCNB1

NUF2

CUL1

CDC45

CDC7

PSMD14

CEP152

NCAPH2

CDC20

NUP107

FEN1

MCM2

CHEK1

RPS27A

HAUS1

NDC1

CDCA8

NUP133

PCNA

MCM3

GMNN

 

HAUS2

NUP153

CDK1

NUP160

POLA1

MCM4

MCM10

 

HAUS3

NUP155

CENPF

NUP85

POLA2

MCM5

MDC1

 

HAUS4

NUP205

CENPH

PLK1

POLE

MCM6

MND1

 

HAUS5

NUP210

CENPI

RCC2

PRIM1

MCM7

TOP3A

 

HAUS6

NUP50

CENPO

SKA1

PRIM2

ORC6

TOPBP1

 

HAUS8

NUP93

CENPQ

SPC24

 

RFC2

TPX2

 

KIF20A

SMC2

CENPU

SPC25

 

RFC4

WHSC1

 

MASTL

SMC4

ERCC6L

XPO1

 

RFC5

  

NCAPD2

VRK1

INCENP

ZW10

    

NCAPD3

 

KIF2C

ZWILCH

    

NCAPG

 

KNTC1

ZWINT

    
  1. STRING version 11.0 was used to conduct the enrichment analysis. Experimentally tested genes are highlighted in bold face. ‘M’ and ‘S’ each represents genes specific the M and S phase, respectively. ‘M checkpoint’ and ‘S checkpoint’ each means genes specific to M and S phase check point regulation, respectively, which were obtained by taking the intersection of genes between ‘M phase’ or ‘S phase’ and ‘cell cycle checkpoint’ pathways. ‘Common’ and ‘Rest’ each represents genes present in and absent from all ‘M’, ‘M checkpoint’, ‘S’, ‘S checkpoint’ categories, respectively